✦ LIBER ✦

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5 year results of a phase 2 trial

✍ Scribed by B. Langdahl⁎; N. Binkley; H. Bone; N. Gilchrist; H. Resch; J. Rodriguez Portales; A. Lombardi; A. Denker; C.L.B.D.T. Le Bailly De Tilleghem; C. DaSilva; E. Rosenberg; A. Leung

Book ID: 116325235
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 153 KB
Volume: 50
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2012.02.127

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with the cathepsin K inhibitor

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5 year results of a phase 2 trial

✍ H. Resch; N. Binkley; H. Bone; J.A. Eisman; N. Gilchrist; B. Langdahl; J. Rodrig 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Treatment With the Cathepsin K Inhibitor

Treatment With the Cathepsin K Inhibitor Odanacatib in Postmenopausal Women With Low BMD: 5 Year Results of a Phase 2 Trial

✍ Watts, Nelson; Binkley, Neil; Bone, Henry; Gilchrist, Nigel; Langdahl, Bente; Re 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 222 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of a cathepsin-K inhibitor in the treatment of postmenopausal women with Low BMD: 18 month results

✍ Avery Ince; Michael McClung; Henry Bone; Nadia Verbruggen; Andrea Rybak-Feiglin; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Four-year results of a phase 2 study of

Four-year results of a phase 2 study of the cathepsin K inhibitor odanacatib in postmenopausal women with low bone mineral density: Effects on bone mineral density and bone turnover markers

✍ H. Resch; N. Binkley; H. Bone; J. Eisman; D. Hosking; B. Langdahl; M. McClung; I 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Four-year Results of a Phase 2 Study of

Four-year Results of a Phase 2 Study of the Cathepsin K Inhibitor Odanacatib in Postmenopausal Women with Low Bone Mineral Density: Effects on Bone Mineral Density and Bone Turnover Markers

✍ Miller, Paul; Binkley, Neil; Eisman, John; Reid, Ian; Lombardi, Antonio 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Study of Odanacatib (MK-822) In The Treatment of Postmenopausal Women With Low BMD: 18-Month Results

✍ Cosman, Felicia; McClung, Michael; Rybak-Feiglin, Andrea; daSilva, Carolyn; Sant 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5&#xa0;year results of a phase 2 trial

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5 year results of a phase 2 trial